申请人:Yeung Kap-Sun
公开号:US20080226592A1
公开(公告)日:2008-09-18
The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
该发明涵盖了式I的化合物,其药用盐,组合物以及使用这些化合物的方法。这些化合物对丙型肝炎病毒(HCV)具有活性,并可用于治疗感染HCV的患者。